Viewing data from:

CLORAZEPATE DIPOTASSIUM

ANDA

CLORAZEPATE DIPOTASSIUM | A075731 | TARO PHARMACEUTICAL INDUSTRIES LTD

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: TRANXENE(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-10-21 | 8 NDCs

Highest NADAC/Unit

$0.7773

per ea

Lowest NADAC/Unit

$0.5189

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
51672404301CLORAZEPATE 7.5 MG TABLET	$0.7773	EA	Generic	—	2026-10-21
51672404302CLORAZEPATE 7.5 MG TABLET	$0.7773	EA	Generic	—	2026-10-21
72603011301CLORAZEPATE 7.5 MG TABLET	$0.7773	EA	Generic	—	2026-10-21
51672404401CLORAZEPATE 15 MG TABLET	$0.7718	EA	Generic	—	2026-10-21
72603011401CLORAZEPATE 15 MG TABLET	$0.7718	EA	Generic	—	2026-10-21
51672404202CLORAZEPATE 3.75 MG TABLET	$0.5189	EA	Generic	—	2026-10-21
51672404201CLORAZEPATE 3.75 MG TABLET	$0.5189	EA	Generic	—	2026-10-21
72603011201CLORAZEPATE 3.75 MG TABLET	$0.5189	EA	Generic	—	2026-10-21

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 5 NDCs (5 FSS)

Lowest Price

$97.50

Highest Price

$915.01

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
51672-4042-01CLORAZEPATE DIPOTASSIUM 3.75MG TAB	$97.50	FSS	Golden State Medical Supply, Inc.	06/14/2028
51672-4042-02CLORAZEPATE DIPOTASSIUM 3.75MG TAB	$841.98	FSS	Golden State Medical Supply, Inc.	06/14/2028
51672-4043-01CLORAZEPATE DIPOTASSIUM 7.5MG TAB	$139.01	FSS	Golden State Medical Supply, Inc.	06/14/2028
51672-4043-02CLORAZEPATE DIPOTASSIUM 7.5MG TAB	$915.01	FSS	Golden State Medical Supply, Inc.	06/14/2028
51672-4044-01CLORAZEPATE DIPOTASSIUM 15MG TAB	$227.54	FSS	Golden State Medical Supply, Inc.	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain4 active DMFs6 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

CAMBREX PROFARMACO MILANO SRLCLORAZEPATE DIPOTASSIUM

DMF 42401981

TARO PHARMACEUTICAL INDUSTRIES LTDCLORAZEPATE DIPOTASSIUM USP

DMF 141691999

HONOUR LAB LTDCLORAZEPATE DIPOTASSIUM

DMF 374752022

APITORIA PHARMA PRIVATE LTDCLORAZEPATE DIPOTASSIUM USP

DMF 413372025

INDUSTRIA CHIMICA PROFARMACO SPAInactiveCLORAZEPATE DIPOTASSIUM, BULK FORM

DMF 39781980

SANOFI SAInactiveCLORAZEPATE DIPOTASSIUM

DMF 42571981

ABBVIE INCInactiveCLORAZEPATE DIPOTASSIUM (TRANXENE)

DMF 45351982

FABBRICA ITALIANA SINTETICI SPAInactiveCLORAZEPATE DIPOTASSIUM

DMF 59221985

WISCONSIN ANALYTICAL AND RESEARCH SERVICES LTDInactiveCLORAZEPATE

DMF 72621987

SUN PHARMACEUTICAL INDUSTRIES LTDInactiveCLORAZEPATE DIPOTASSIUM USP

DMF 169802003

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Apr 27, 2000	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (3)

Sort:

#001 — 15MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Apr 27, 2000

No patent or exclusivity listings for this strength.

#002 — 7.5MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Apr 27, 2000

#003 — 3.75MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Apr 27, 2000